ReviewJournal of hematology & oncology2020

Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies.

Yonghan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.